• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将随机试验中个体的因果推断推广到所有符合试验条件的个体。

Generalizing causal inferences from individuals in randomized trials to all trial-eligible individuals.

作者信息

Dahabreh Issa J, Robertson Sarah E, Tchetgen Eric J, Stuart Elizabeth A, Hernán Miguel A

机构信息

Center for Evidence Synthesis in Health, Brown University School of Public Health, Providence, Rhode Island.

Departments of Health Services, Policy & Practice and Epidemiology, Brown University, Providence, Rhode Island.

出版信息

Biometrics. 2019 Jun;75(2):685-694. doi: 10.1111/biom.13009. Epub 2019 Jun 21.

DOI:10.1111/biom.13009
PMID:30488513
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10938232/
Abstract

We consider methods for causal inference in randomized trials nested within cohorts of trial-eligible individuals, including those who are not randomized. We show how baseline covariate data from the entire cohort, and treatment and outcome data only from randomized individuals, can be used to identify potential (counterfactual) outcome means and average treatment effects in the target population of all eligible individuals. We review identifiability conditions, propose estimators, and assess the estimators' finite-sample performance in simulation studies. As an illustration, we apply the estimators in a trial nested within a cohort of trial-eligible individuals to compare coronary artery bypass grafting surgery plus medical therapy vs. medical therapy alone for chronic coronary artery disease.

摘要

我们考虑在符合试验条件个体的队列中进行的随机试验中的因果推断方法,包括未被随机分组的个体。我们展示了如何利用来自整个队列的基线协变量数据,以及仅来自随机分组个体的治疗和结局数据,来识别所有符合条件个体的目标人群中的潜在(反事实)结局均值和平均治疗效果。我们回顾了可识别性条件,提出了估计量,并在模拟研究中评估了估计量的有限样本性能。作为一个示例,我们将这些估计量应用于一个嵌套在符合试验条件个体队列中的试验,以比较冠状动脉旁路移植术加药物治疗与单纯药物治疗对慢性冠状动脉疾病的疗效。

相似文献

1
Generalizing causal inferences from individuals in randomized trials to all trial-eligible individuals.将随机试验中个体的因果推断推广到所有符合试验条件的个体。
Biometrics. 2019 Jun;75(2):685-694. doi: 10.1111/biom.13009. Epub 2019 Jun 21.
2
Extending inferences from a randomized trial to a new target population.将随机试验的推断扩展到新的目标人群。
Stat Med. 2020 Jun 30;39(14):1999-2014. doi: 10.1002/sim.8426. Epub 2020 Apr 6.
3
Study Designs for Extending Causal Inferences From a Randomized Trial to a Target Population.从随机试验到目标人群推广因果推论的研究设计。
Am J Epidemiol. 2021 Aug 1;190(8):1632-1642. doi: 10.1093/aje/kwaa270.
4
Efficient and robust methods for causally interpretable meta-analysis: Transporting inferences from multiple randomized trials to a target population.高效稳健的因果可解释荟萃分析方法:将多个随机试验的推论推广到目标人群。
Biometrics. 2023 Jun;79(2):1057-1072. doi: 10.1111/biom.13716. Epub 2023 Feb 7.
5
Estimating Subgroup Effects in Generalizability and Transportability Analyses.在可推广性和可转移性分析中估计亚组效应。
Am J Epidemiol. 2024 Jan 8;193(1):149-158. doi: 10.1093/aje/kwac036.
6
Improving transportability of randomized controlled trial inference using robust prediction methods.使用稳健预测方法提高随机对照试验推论的可转移性。
Stat Methods Med Res. 2023 Dec;32(12):2365-2385. doi: 10.1177/09622802231210944. Epub 2023 Nov 7.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
Identifiability and estimation of causal effects in randomized trials with noncompliance and completely nonignorable missing data.存在不依从性和完全不可忽略缺失数据的随机试验中因果效应的可识别性与估计
Biometrics. 2009 Sep;65(3):675-82. doi: 10.1111/j.1541-0420.2008.01120.x. Epub 2008 Aug 28.
9
Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization.参加冠状动脉介入试验的患者不能代表临床实践中的患者:欧洲冠状动脉血运重建调查结果
Eur Heart J. 2006 Mar;27(6):671-8. doi: 10.1093/eurheartj/ehi731. Epub 2006 Jan 19.
10
Comparing outcomes of percutaneous transluminal coronary angioplasty with coronary artery bypass grafting; can routine health service data complement and enhance randomized controlled trials?比较经皮腔内冠状动脉成形术与冠状动脉旁路移植术的治疗结果;常规医疗服务数据能否补充并加强随机对照试验?
Eur Heart J. 1999 Dec;20(23):1731-5. doi: 10.1053/euhj.1999.1690.

引用本文的文献

1
Improving efficiency in transporting average treatment effects.提高平均治疗效果的运输效率。
Biometrika. 2025;112(3). doi: 10.1093/biomet/asaf027. Epub 2025 Apr 8.
2
Assessment of treatment effect heterogeneity for multiregional randomized clinical trials.多区域随机临床试验治疗效果异质性评估
Stat Biopharm Res. 2025;17(3):315-322. doi: 10.1080/19466315.2024.2421748. Epub 2024 Dec 20.
3
Modeling Versus Balancing Approaches to Addressing Instrumental Variables in Weighting: A Comparison of the Outcome-Adaptive Lasso, Stable Balancing Weighting, and Stable Confounder Selection.

本文引用的文献

1
Model misspecification and bias for inverse probability weighting estimators of average causal effects.模型误设定和平均因果效应逆概率加权估计的偏差。
Biom J. 2023 Feb;65(2):e2100118. doi: 10.1002/bimj.202100118. Epub 2022 Aug 31.
2
On Inverse Probability Weighting for Nonmonotone Missing at Random Data.关于随机缺失非单调数据的逆概率加权法
J Am Stat Assoc. 2018;113(521):369-379. doi: 10.1080/01621459.2016.1256814. Epub 2017 Dec 1.
3
Reflection on modern methods: selection bias-a review of recent developments.反思现代方法:选择偏差——近期发展综述。
加权中处理工具变量的建模与平衡方法:结果自适应套索法、稳定平衡加权法和稳定混杂因素选择法的比较
Pharmacoepidemiol Drug Saf. 2025 Jul;34(7):e70173. doi: 10.1002/pds.70173.
4
Generalizability Analyses with a Partially Nested Trial Design: The Necrotizing Enterocolitis Surgery Trial.部分嵌套试验设计的可推广性分析:坏死性小肠结肠炎手术试验
Epidemiology. 2025 Jun 5. doi: 10.1097/EDE.0000000000001875.
5
Keep asking: What do I want? What do I have? What do I do? : An approach for combining information to learn about a target population.不断追问:我想要什么?我拥有什么?我做了什么?:一种整合信息以了解目标人群的方法。
Eur J Epidemiol. 2025 May 28. doi: 10.1007/s10654-025-01222-z.
6
Using negative controls to identify causal effects with invalid instrumental variables.使用阴性对照来识别无效工具变量的因果效应。
Biometrika. 2024 Nov 22;112(1):asae064. doi: 10.1093/biomet/asae064. eCollection 2025.
7
Design considerations and challenges in the CHinA National CancEr Screening (CHANCES) trial and Tomosynthesis Mammographic Imaging Screening Trial (TMIST).中国国家癌症筛查(CHANCES)试验和乳腺断层合成钼靶成像筛查试验(TMIST)中的设计考量与挑战。
J Natl Cancer Inst Monogr. 2025 Mar 1;2025(68):42-48. doi: 10.1093/jncimonographs/lgae049.
8
What works for whom in pediatric OCD: description of causally interpretable meta-analysis methods and report on trial data harmonization.儿科强迫症中何种疗法对何人有效:因果可解释的荟萃分析方法描述及试验数据协调报告
Psychol Med. 2025 Feb 6;55:e27. doi: 10.1017/S0033291724003301.
9
Comparison of sample characteristics of Wisconsin Alzheimer's Disease Research Center participants with the Wisconsin state population-An evaluation of the recruitment effort.威斯康星州阿尔茨海默病研究中心参与者与威斯康星州人口的样本特征比较——招募工作评估
Alzheimers Dement (N Y). 2025 Jan 16;11(1):e70036. doi: 10.1002/trc2.70036. eCollection 2025 Jan-Mar.
10
Synthesis estimators for transportability with positivity violations by a continuous covariate.用于处理连续协变量违反正性假设的可移植性的合成估计量。
J R Stat Soc Ser A Stat Soc. 2024 Sep 2;188(1):158-180. doi: 10.1093/jrsssa/qnae084. eCollection 2025 Jan.
Int J Epidemiol. 2018 Oct 1;47(5):1714-1722. doi: 10.1093/ije/dyy138.
4
Robust estimation of encouragement-design intervention effects transported across sites.跨站点传递的鼓励设计干预效果的稳健估计。
J R Stat Soc Series B Stat Methodol. 2017 Nov;79(5):1509-1525. doi: 10.1111/rssb.12213. Epub 2016 Oct 31.
5
Randomized, Controlled Trials in Health Insurance Systems.医疗保险系统中的随机对照试验。
N Engl J Med. 2017 Sep 7;377(10):957-964. doi: 10.1056/NEJMra1510058.
6
Using group data to treat individuals: understanding heterogeneous treatment effects in the age of precision medicine and patient-centred evidence.使用群体数据治疗个体:在精准医学和以患者为中心的证据时代理解异质性治疗效果。
Int J Epidemiol. 2016 Dec 1;45(6):2184-2193. doi: 10.1093/ije/dyw125.
7
Pragmatic Trials.实用性试验
N Engl J Med. 2016 Aug 4;375(5):454-63. doi: 10.1056/NEJMra1510059.
8
Integrating Randomized Comparative Effectiveness Research with Patient Care.将随机对照有效性研究与患者护理相结合。
N Engl J Med. 2016 Jun 2;374(22):2152-8. doi: 10.1056/NEJMra1510057.
9
New methods for treatment effect calibration, with applications to non-inferiority trials.治疗效果校准的新方法及其在非劣效性试验中的应用。
Biometrics. 2016 Mar;72(1):20-9. doi: 10.1111/biom.12388. Epub 2015 Sep 13.
10
Variance reduction in randomised trials by inverse probability weighting using the propensity score.利用倾向评分的逆概率加权法减少随机试验中的方差。
Stat Med. 2014 Feb 28;33(5):721-37. doi: 10.1002/sim.5991. Epub 2013 Sep 30.